St Renatus Drug Patent Portfolio
St Renatus owns 1 orange book drug protected by 3 US patents Given below is the list of St Renatus's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8580282 | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | 02 Apr, 2030 | Active |
| US9308191 | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | 02 Apr, 2030 | Active |
| US6413499 | Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic | 20 Mar, 2020 | Expired |
Latest Legal Activities on St Renatus's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of St Renatus.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 20 May, 2024 | US9308191 |
|
Maintenance Fee Reminder Mailed
Critical
| 04 Dec, 2023 | US9308191 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 28 Apr, 2021 | US8580282 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 27 Sep, 2019 | US9308191 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 06 Apr, 2018 | US9308191 |
|
Email Notification
Critical
| 06 Apr, 2018 | US9308191 |
|
Email Notification
Critical
| 05 Apr, 2018 | US8580282 |
|
Correspondence Address Change
Critical
| 05 Apr, 2018 | US9308191 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 05 Apr, 2018 | US8580282 |
|
Correspondence Address Change
Critical
| 04 Apr, 2018 | US8580282 |
|
Correspondence Address Change
Critical
| 08 Nov, 2017 | US9308191 |
|
Correspondence Address Change
Critical
| 08 Nov, 2017 | US8580282 |
|
Patent Term Extension (156) Dismissed
Critical
| 30 Aug, 2017 | US8580282 |
|
Patent Term Extension (156) Dismissed
Critical
| 30 Aug, 2017 | US9308191 |
| Letter from FDA or Dept of Agriculture re PTE application | 12 Jul, 2017 | US8580282 |
St Renatus's Family Patents
St Renatus Drug List
Given below is the complete list of St Renatus's drugs and the patents protecting them.
1. Kovanaze
Kovanaze is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8580282 | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration |
02 Apr, 2030
(5 years from now)
| Active |
| US9308191 | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration |
02 Apr, 2030
(5 years from now)
| Active |
| US6413499 | Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic |
20 Mar, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kovanaze's drug page